SunBio,Inc. (KOSDAQ:067370)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,100.00
+780.00 (10.66%)
At close: Apr 24, 2026
Market Cap98.77B +24.6%
Revenue (ttm)2.17B +2.3%
Net Income1.39B
EPS249.33
Shares Out12.19M
PE Ratio32.49
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume121,846
Average Volume35,128
Open7,280.00
Previous Close7,320.00
Day's Range7,270.00 - 8,240.00
52-Week Range4,840.00 - 10,170.00
Beta0.35
RSI81.98
Earnings Daten/a

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 067370
Full Company Profile